APA (7th ed.) Citation

AH, B., KK, T., DY, O., & MA, A. (2021). Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors. Clinical science (London, England : 1979), 135(5), 703. https://doi.org/10.1042/CS20200331

Chicago Style (17th ed.) Citation

AH, Baik, Tsai KK, Oh DY, and Aras MA. "Mechanisms and Clinical Manifestations of Cardiovascular Toxicities Associated with Immune Checkpoint Inhibitors." Clinical Science (London, England : 1979) 135, no. 5 (2021): 703. https://doi.org/10.1042/CS20200331.

MLA (9th ed.) Citation

AH, Baik, et al. "Mechanisms and Clinical Manifestations of Cardiovascular Toxicities Associated with Immune Checkpoint Inhibitors." Clinical Science (London, England : 1979), vol. 135, no. 5, 2021, p. 703, https://doi.org/10.1042/CS20200331.